 Kristen Nordenholz
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 17 | 2021 | 226 | 2.370 |
Why?
| | Venous Thromboembolism | 7 | 2022 | 316 | 0.850 |
Why?
| | Fibrin Fibrinogen Degradation Products | 7 | 2016 | 82 | 0.740 |
Why?
| | Emergency Service, Hospital | 15 | 2021 | 2072 | 0.710 |
Why?
| | Emergency Medicine | 3 | 2023 | 226 | 0.430 |
Why?
| | Anticoagulants | 4 | 2021 | 664 | 0.430 |
Why?
| | Tissue Plasminogen Activator | 4 | 2017 | 225 | 0.410 |
Why?
| | Antithrombins | 1 | 2013 | 60 | 0.410 |
Why?
| | Emergency Treatment | 1 | 2013 | 118 | 0.390 |
Why?
| | Fibrinolytic Agents | 4 | 2017 | 271 | 0.390 |
Why?
| | gamma-Glutamyltransferase | 1 | 2012 | 43 | 0.380 |
Why?
| | Venous Thrombosis | 3 | 2016 | 190 | 0.360 |
Why?
| | Hemorrhage | 2 | 2014 | 722 | 0.320 |
Why?
| | Oximetry | 1 | 2009 | 96 | 0.300 |
Why?
| | Patient Care Team | 1 | 2014 | 631 | 0.300 |
Why?
| | Patient Acceptance of Health Care | 1 | 2014 | 807 | 0.270 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2008 | 89 | 0.270 |
Why?
| | Healthcare Disparities | 1 | 2014 | 656 | 0.270 |
Why?
| | Thromboembolism | 1 | 2007 | 119 | 0.260 |
Why?
| | Blood Proteins | 1 | 2008 | 252 | 0.250 |
Why?
| | Burnout, Professional | 2 | 2023 | 442 | 0.250 |
Why?
| | Sensitivity and Specificity | 8 | 2016 | 1946 | 0.250 |
Why?
| | Diagnostic Imaging | 2 | 2008 | 332 | 0.240 |
Why?
| | Prospective Studies | 14 | 2016 | 7623 | 0.210 |
Why?
| | Biomarkers | 3 | 2017 | 4154 | 0.180 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2836 | 0.180 |
Why?
| | Middle Aged | 20 | 2022 | 33554 | 0.170 |
Why?
| | Mass Screening | 2 | 2021 | 1288 | 0.170 |
Why?
| | Muscarinic Antagonists | 1 | 2000 | 29 | 0.160 |
Why?
| | Drug Contamination | 1 | 2000 | 53 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2022 | 162 | 0.160 |
Why?
| | Heroin Dependence | 1 | 2000 | 33 | 0.160 |
Why?
| | Humans | 33 | 2023 | 137782 | 0.150 |
Why?
| | Poisoning | 1 | 2000 | 120 | 0.150 |
Why?
| | Male | 24 | 2022 | 67906 | 0.150 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 318 | 0.140 |
Why?
| | Thrombosis | 1 | 2022 | 371 | 0.140 |
Why?
| | Female | 24 | 2022 | 73465 | 0.140 |
Why?
| | Acute Disease | 3 | 2017 | 1007 | 0.140 |
Why?
| | Predictive Value of Tests | 4 | 2015 | 2041 | 0.130 |
Why?
| | Adult | 16 | 2021 | 38023 | 0.130 |
Why?
| | Rivaroxaban | 2 | 2021 | 255 | 0.130 |
Why?
| | Dyspnea | 2 | 2015 | 254 | 0.120 |
Why?
| | Ultrasonography | 2 | 2016 | 763 | 0.120 |
Why?
| | Abdominal Injuries | 1 | 1997 | 123 | 0.120 |
Why?
| | Risk Factors | 8 | 2021 | 10407 | 0.120 |
Why?
| | Physicians | 1 | 2023 | 914 | 0.110 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 140 | 0.110 |
Why?
| | Quality of Life | 3 | 2015 | 2894 | 0.110 |
Why?
| | beta-Alanine | 1 | 2013 | 16 | 0.110 |
Why?
| | Dabigatran | 1 | 2013 | 22 | 0.110 |
Why?
| | Fibrinolysis | 1 | 2015 | 147 | 0.110 |
Why?
| | Radiology | 1 | 2016 | 180 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 1 | 1997 | 278 | 0.110 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2013 | 34 | 0.110 |
Why?
| | Morpholines | 1 | 2013 | 122 | 0.100 |
Why?
| | Thiophenes | 1 | 2013 | 117 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 4 | 2015 | 2697 | 0.100 |
Why?
| | Benzimidazoles | 1 | 2013 | 170 | 0.100 |
Why?
| | Aged | 9 | 2021 | 24001 | 0.090 |
Why?
| | Pyridones | 1 | 2013 | 168 | 0.090 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 238 | 0.090 |
Why?
| | Probability | 2 | 2014 | 304 | 0.090 |
Why?
| | Diagnosis, Differential | 3 | 2015 | 1483 | 0.090 |
Why?
| | Administration, Oral | 1 | 2013 | 816 | 0.090 |
Why?
| | Radiation Injuries | 1 | 2012 | 145 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2015 | 421 | 0.090 |
Why?
| | Pyrazoles | 1 | 2013 | 424 | 0.080 |
Why?
| | Heparin | 1 | 2012 | 261 | 0.080 |
Why?
| | Retrospective Studies | 5 | 2022 | 15682 | 0.080 |
Why?
| | Medical History Taking | 1 | 2010 | 117 | 0.080 |
Why?
| | Physical Examination | 1 | 2010 | 241 | 0.070 |
Why?
| | False Negative Reactions | 1 | 2008 | 53 | 0.070 |
Why?
| | Peroxidase | 1 | 2008 | 175 | 0.070 |
Why?
| | Area Under Curve | 1 | 2008 | 314 | 0.070 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2007 | 13 | 0.070 |
Why?
| | Quality of Health Care | 1 | 2012 | 642 | 0.070 |
Why?
| | Research Design | 1 | 2013 | 1139 | 0.070 |
Why?
| | HIV Infections | 1 | 2021 | 2837 | 0.070 |
Why?
| | Inflammation | 1 | 2017 | 2838 | 0.060 |
Why?
| | Critical Care | 1 | 2012 | 610 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 629 | 0.060 |
Why?
| | C-Reactive Protein | 1 | 2008 | 410 | 0.060 |
Why?
| | Observer Variation | 1 | 2007 | 343 | 0.060 |
Why?
| | Algorithms | 2 | 2008 | 1704 | 0.060 |
Why?
| | Logistic Models | 4 | 2012 | 2075 | 0.060 |
Why?
| | Odds Ratio | 3 | 2012 | 1070 | 0.050 |
Why?
| | Cohort Studies | 1 | 2014 | 5750 | 0.050 |
Why?
| | Risk Assessment | 2 | 2012 | 3461 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 92 | 0.040 |
Why?
| | Faculty | 1 | 2022 | 147 | 0.040 |
Why?
| | Decision Trees | 1 | 2021 | 93 | 0.040 |
Why?
| | Indiana | 1 | 2020 | 34 | 0.040 |
Why?
| | Symptom Assessment | 1 | 2022 | 128 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 201 | 0.040 |
Why?
| | Mid-Atlantic Region | 1 | 2000 | 5 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2022 | 207 | 0.040 |
Why?
| | Cough | 1 | 2021 | 122 | 0.040 |
Why?
| | Heroin | 1 | 2000 | 31 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2000 | 132 | 0.040 |
Why?
| | Fever | 1 | 2021 | 306 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 310 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2014 | 1997 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2010 | 329 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2021 | 10837 | 0.040 |
Why?
| | Adolescent | 4 | 2013 | 21574 | 0.040 |
Why?
| | Survival Analysis | 1 | 2021 | 1325 | 0.040 |
Why?
| | United States | 4 | 2021 | 14870 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2009 | 1910 | 0.040 |
Why?
| | Convalescence | 1 | 2017 | 17 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2022 | 546 | 0.030 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1509 | 0.030 |
Why?
| | Peritoneal Lavage | 1 | 1997 | 8 | 0.030 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 1997 | 30 | 0.030 |
Why?
| | Health Personnel | 1 | 2023 | 711 | 0.030 |
Why?
| | Disease Outbreaks | 1 | 2000 | 395 | 0.030 |
Why?
| | Length of Stay | 1 | 2021 | 1215 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 744 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2021 | 364 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2007 | 7637 | 0.030 |
Why?
| | Registries | 2 | 2021 | 2041 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1357 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1639 | 0.030 |
Why?
| | Angiography | 1 | 2015 | 207 | 0.030 |
Why?
| | Wounds, Gunshot | 1 | 1997 | 228 | 0.030 |
Why?
| | Suicide, Attempted | 1 | 1997 | 382 | 0.030 |
Why?
| | Shock | 1 | 2014 | 98 | 0.020 |
Why?
| | Contrast Media | 1 | 2015 | 467 | 0.020 |
Why?
| | Lower Extremity | 1 | 2016 | 434 | 0.020 |
Why?
| | Unnecessary Procedures | 1 | 2012 | 50 | 0.020 |
Why?
| | APACHE | 1 | 2012 | 69 | 0.020 |
Why?
| | Echocardiography | 1 | 2015 | 644 | 0.020 |
Why?
| | Blood Coagulation Tests | 1 | 2012 | 67 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 282 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 431 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5478 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1067 | 0.020 |
Why?
| | Factor Xa Inhibitors | 1 | 2012 | 172 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1997 | 760 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 822 | 0.020 |
Why?
| | Bundle-Branch Block | 1 | 2009 | 31 | 0.020 |
Why?
| | Tachycardia | 1 | 2009 | 57 | 0.020 |
Why?
| | Thrombophilia | 1 | 2010 | 83 | 0.020 |
Why?
| | Chest Pain | 1 | 2010 | 91 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5793 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2009 | 144 | 0.020 |
Why?
| | Child | 2 | 2007 | 21989 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1316 | 0.020 |
Why?
| | Clinical Competence | 1 | 2016 | 1129 | 0.020 |
Why?
| | Databases as Topic | 1 | 2008 | 67 | 0.020 |
Why?
| | ROC Curve | 1 | 2008 | 554 | 0.020 |
Why?
| | Time Factors | 1 | 2015 | 6834 | 0.010 |
Why?
| | Age Factors | 1 | 2012 | 3305 | 0.010 |
Why?
| | Sex Factors | 1 | 2010 | 2077 | 0.010 |
Why?
| | Quality Improvement | 1 | 2012 | 1181 | 0.010 |
Why?
| | Obesity | 1 | 2015 | 2993 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2012 | 2659 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 13240 | 0.010 |
Why?
| | Age Distribution | 1 | 1997 | 392 | 0.010 |
Why?
| | Sex Distribution | 1 | 1997 | 375 | 0.010 |
Why?
| | Self-Injurious Behavior | 1 | 1997 | 131 | 0.010 |
Why?
| | Survival Rate | 1 | 1997 | 1973 | 0.010 |
Why?
| | Firearms | 1 | 1997 | 386 | 0.010 |
Why?
| | Incidence | 1 | 1997 | 2804 | 0.010 |
Why?
| | Mental Disorders | 1 | 1997 | 1077 | 0.000 |
Why?
| | Child, Preschool | 1 | 1997 | 11105 | 0.000 |
Why?
|
|
Nordenholz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|